Vincenti F - Search Results

1

De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco.

Vincenti F, Stock P. Vincenti F, et al. Transplant Proc. 2003 May;35(3 Suppl):183S-186S. doi: 10.1016/s0041-1345(03)00237-9. Transplant Proc. 2003. PMID: 12742494

2

Cytokine and T cell receptor gene expression at the site of allograft rejection.

Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJ, Melzer J, Garovoy MR, Roberts JP, et al. Krams SM, et al. Among authors: vincenti f. Transplantation. 1992 Jan;53(1):151-6. doi: 10.1097/00007890-199201000-00031. Transplantation. 1992. PMID: 1733064

3

Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol.

Salvatierra O, McVicar J, Melzer J, Amend W, Vincenti F, Tomlanovich S, Husing R, Rabkin J, Garovoy M. Salvatierra O, et al. Among authors: vincenti f. Transplant Proc. 1991 Feb;23(1 Pt 2):1024-6. Transplant Proc. 1991. PMID: 1989146

4

Inability of cyclosporine to completely prevent the recurrence of focal glomerulosclerosis after kidney transplantation.

Vincenti F, Biava C, Tomlanovitch S, Amend WJ Jr, Garovoy M, Melzer J, Feduska N, Salvatierra O Jr. Vincenti F, et al. Transplantation. 1989 Apr;47(4):595-8. doi: 10.1097/00007890-198904000-00006. Transplantation. 1989. PMID: 2650043

5

Successful management of the highly sensitized renal allograft recipient.

Melzer JS, Husing R, Lou C, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O Jr. Melzer JS, et al. Among authors: vincenti f. Transplant Proc. 1989 Feb;21(1 Pt 1):751-3. Transplant Proc. 1989. PMID: 2650256 No abstract available.

6

The incidence and impact of herpes simplex virus infections in the first month following renal transplantation.

Tomlanovich SJ, Sabatte-Caspillo J, Melzer J, Amend W, Vincenti F, Feduska N, Salvatierra O. Tomlanovich SJ, et al. Among authors: vincenti f. Transplant Proc. 1989 Feb;21(1 Pt 2):2091-2. Transplant Proc. 1989. PMID: 2652674 No abstract available.

7

Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?

Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O Jr. Melzer JS, et al. Among authors: vincenti f. Transplant Proc. 1987 Feb;19(1 Pt 3):1971-3. Transplant Proc. 1987. PMID: 2856274 No abstract available.

8

Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipients.

Feduska NJ, Melzer JS, Amend WJ Jr, Vincenti F, Tomlanovich SJ, Garovoy M, Husing R, Salvatierra O Jr. Feduska NJ, et al. Among authors: vincenti f. Transplant Proc. 1988 Jun;20(3 Suppl 3):102-9. Transplant Proc. 1988. PMID: 3291212 No abstract available.

9

How to improve results for second renal allografts.

Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ Jr, Garovoy M, Lou C, Salvatierra O Jr. Melzer JS, et al. Among authors: vincenti f. Transplant Proc. 1988 Jun;20(3 Suppl 3):176-9. Transplant Proc. 1988. PMID: 3291238 No abstract available.

10

Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.

Orloff SL, Stempel CA, Wright TL, Tomlanovich SJ, Amend WJ, Stock PG, Melzer JS, Vincenti F. Orloff SL, et al. Among authors: vincenti f. Clin Transplant. 1995 Apr;9(2):119-24. Clin Transplant. 1995. PMID: 7599400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters